Company research / NXTC
NextCure, Inc. (NXTC)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2020-12-31, NextCure, Inc. reported revenue of $22.38M. Revenue grew 252.6% from the prior annual period.
Key ratios (year ended 2020-12-31)
-184.2%
Operating margin
-163.6%
Net margin
-12.5%
Return on year-end equity
252.6%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.